The DOI matches its Crossref record; 73 of the 74 references it cites were found in a registry or an index.
Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms
Open accessAbstract
Mutations in the microtubule-associated protein tau gene have been linked to neurofibrillary tangle (NFT) formation in several neurodegenerative diseases known as tauopathies; however, no tau mutations occur in Alzheimer's disease, although this disease is also characterized by NFT formation and cell death. Importantly, the mechanism of tau-mediated neuronal death remains elusive. Aged mice expressing nonmutant human tau in the absence of mouse tau (htau mice) developed NFTs and extensive cell death. The mechanism of neuron death was investigated in htau mice, and surprisingly, the presence of tau filaments did not correlate directly with death within individual cells, suggesting that cell death can occur independently of NFT formation. Our observations show that the mechanism of neurodegeneration involved reexpression of cell-cycle proteins and DNA synthesis, indicating that nonmutant tau pathology and neurodegeneration may be linked via abnormal, incomplete cell-cycle reentry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, neuronal loss appears to be independent of tangle formation in some transgenic mouse models (12)(13)(14).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · cited 4×
“A number of studies have detected DNA fragmentation, a hallmark of apoptosis, in AD tissue sections using the terminal deoxynucleotide transferase mediated dUTP nick-end labeling (TUNEL) method (Gavrieli et al., 1992; Sgonc and Wick, 1994) to identify 3 -OH ends of broken DNA (Su et al.”
MethodInfluentialAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“However, no mutations have been found in the tau gene in AD, and the relationship between tau pathology, amyloid deposition, and neuronal degeneration is difficult to determine (Hardy and Higgins, 1992; Taylor et al., 2002).”
BackgroundNeurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · cited 1×
“…life in specific brain regions, including the subventricular zone of the lateral ventricles and the subgranular zone of the dentate gyrus of the hippocampus (Eriksson et al., 1998; Gould et al., 1998), but it does not normally occur in most regions with large populations of postmitotic neurons.”
BackgroundHengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779 · cited 2×
“These pathways are classically grouped based on stereotyped changes in nuclear morphology (Kerr, 1972; Leist and Jaattela, 2001), principally with respect to chromatin condensation, and on the presence or absence of the classic cell executioners: the caspases (for review, see Hengartner, 2000).”
BackgroundThe Ki-67 protein: From the known and the unknown
Scholzen, T. E., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3 · Cited by 4,707
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“Mutations in the tau gene have been linked to NFT formation in a number of tauopathies in which no -amyloid deposits develop (Hutton et al., 1998; Spillantini et al., 1998; Poorkaj et al., 2001).”
BackgroundSelf-citationWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994 · cited 1×
“The optical fractionator (West et al., 1991) was used to obtain quantitative estimates of neuronal loss with age in the htau mice.”
MethodFour deaths and a funeral: from caspases to alternative mechanisms
Leist, M., & Jäättelä, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085008 · Cited by 1,600 · cited 2×
“These pathways are classically grouped based on stereotyped changes in nuclear morphology (Kerr, 1972; Leist and Jaattela, 2001), principally with respect to chromatin condensation, and on the presence or absence of the classic cell executioners: the caspases (for review, see Hengartner, 2000).”
BackgroundMethodNeuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · cited 1×
“Moreover, there is evidence to suggest that some neurons in AD brain may die without forming NFTs (Gomez-Isla et al., 1997).”
Background
Research works printed but not linked: 5
- 1989, Mol Cell Biol, 9, 1389
- Hof PR (2000) Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains. Amsterdam: Elsevier.
- 1996, Cancer Res, 56, 816
- 1996, Dementia, 7, 177
- 2003, Prog Cell Cycle Res, 5, 31
Cited by
Sorted by citations
Items 401–466 of 466
Heat Shock Proteins and Neurodegenerative Diseases
Brown, I. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-39717-7_18 · Cited by 10
Advancing Alzheimer’s research by improving disease modeling of secondary tauopathy
Roy, E. R., & Cao, W. (2025) · npj Dementia · doi:10.1038/s44400-025-00044-w · Cited by 4
“A transgenic mouse line of WT human tau overexpression generated by the Davies laboratory 42 displayed tau hyperphosphorylation and fi lamentous aggregation, neuronal cell death 43 , and synaptic and cognitive dysfunction 44 .”
Lim, M. J., Boschen, S. L., Kurti, A., Casey, M. C., Phillips, V. R., Fryer, J. D., Dickson, D. W., Jansen‐West, K. R., Petrucelli, L., Delenclos, M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102863 · Cited by 4
“Later in life (>15 months), thioflavine-S-positive neurofibrillary tangles (NFTs) have also been reported [22,26].”
BackgroundBowles, K., Pugh, D., Pedicone, C., Oja, L., Weitzman, S., Liu, Y., Chen, J.-L., Disney, M., & Goate, A. (2023) · bioRxiv · doi:10.1101/2023.06.02.543224 · Cited by 4
Li, S., Roy, E. R., Wang, Y., Watkins, T. A., & Cao, W. (2023) · Research Square · doi:10.21203/rs.3.rs-2617457/v1 · Cited by 3
Ferrer, I., Andrés‐Benito, P., Ausín, K., Cartas‐Cejudo, P., Lachén‐Montes, M., del Rı́o, J. A., Fernández‐Irigoyen, J., & Santamaría, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126427 · Cited by 4
“Cg- (GFP)Klt Tg(MAPT)8cPdav/J) in a C57BL/6 background (Jackson laboratories; reference: RRID:IMSR_JAX:005491; Bar Harbor, ME, USA) [31,32].”
BackgroundThe Role of Glycogen Synthase Kinase-3 (GSK-3) in Alzheimer’s Disease
Medina, M., & Avil, J. (2011) · InTech eBooks · doi:10.5772/16879 · Cited by 7
“In fact, there is some evidence suggesting that NFT might be protective indeed, as tangle-bearing neurons seem to survive for long periods of time (Andorfer et al., 2005; de Calignon et al., 2009; Morsch et al., 1999).”
BackgroundSahara, N., & Lewis, J. M. (2010) · Future Neurology · doi:10.2217/fnl.10.10 · Cited by 5
“The tauopathy in the Htau model is somewhat slow to develop; mice older than 15 months of age developed tauopathy, DNA fragmentation and a quantitative loss of neurons [58,59].”
BackgroundTau-induced neurodegeneration: A clue to its mechanism
Alonso, A. D. C., & Iqbal, K. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-8301 · Cited by 4
“Even more, the cells that accumulate filamentous tau appear “healthy” in terms of nuclear morphology, suggesting that the polymerized protein is protective for the neurons [7].”
THE ROLE OF MICROTUBULE-ASSOCIATED PROTEIN TAU IN NEURONAL EXCITABILITY AND EPILEPTOGENESIS
Cloyd, R. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.271
Aliev, G. M., Burzynski, G. S., Ashraf, G. M., Jabir, N. R., Cacabelos, R., Benberin, V. V., & Burzynski, S. R. (2011) · Springer eBooks · doi:10.1007/978-3-642-30018-9_206 · Cited by 3
“It was observed in transgenic mice expressing nonmutant human tau isoforms that themechanismof neurodegeneration involved reexpression of cell cycle proteins and DNA synthesis, indicating that nonmutant tau pathology and neurodegenerationmay be linked via abnormal, incomplete cell cycle reentry (Andorfer et al. 2005;…”
BackgroundBiologic models of neurodegenerative disorders
Eriksen, J. L., Zehr, C., & Lewis, J. M. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01216-x · Cited by 4
Prospects for Antioxidant Therapy in Mild Cognitive Impairment and Alzheimer's Disease
Nunomura, A., Perry, G. L., & Smith, M. A. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50161-7 · Cited by 4
Genomic and proteomic conversion of brain ischemia to Alzheimer’s disease
Pluta, R. M., & Ułamek-Kozioł, M. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1804251 · Cited by 3
“Other controversial observations suggest that neuronal death coincides with the formation of neurofibrillary tangles, which are composed of hyperphosphorylated tau protein (Andorfer et al., 2005).”
Li, J., Xu, Y., Balboni, G., & Xia, Y. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1587219 · Cited by 3
Pathogenic tau disrupts the cellular program that maintains neuronal identityPreprint
Beckmann, A., Ramirez, P., Gamez-Guijarro, M., Ray, W. J., & Frost, B. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.05.434166 · Cited by 3
Tau in Tauopathies That Leads to Cognitive Disorders and in Cancer
Huda, M. N., & Pan, C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.74025 · Cited by 1
“For normal human tau-expressing transgenic mice, increased tau phosphorylation occurred, along with insoluble tau being found in the brains of aged mice [157].”
BackgroundAnimal Models of Alzheimer’s Disease
Kiyota, T. (2013) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4614-8794-4_35 · Cited by 3
Park, C., Jung, J., Hong, Y., Yoo, H., Yang, K., Shin, J., Kim, M., Lim, C. S., Jeong, A., Hong, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-67888-x · Cited by 2
“Given the link between aberrant cell cycle activation in postmitotic neurons and neurodegeneration 84 – 86 , as well as the reduction of adult hippocampal neurogenesis in cognitive decline 87,88 , it is possible that the defective mitotic function of tau in neurons could have broader implications…”
Smith, E. D., Paterno, G., Bell, B. M., Gorion, K.-M. M., Prokop, S., & Giasson, B. I. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08850-4 · Cited by 7
“WT tau, unlike its mutant counterparts associated with FTDP-17, is generally resistant to aggregation under physiological conditions (Andorfer et al., 2005; Ferrari et al., 2003; Götz et al., 1995).”
Ning, Y., Zhang, Y., Jiang, T., Feng, J., Zhan, J., Ou, C., & Wang, L. (2024) · Neuroscience Research · doi:10.1016/j.neures.2024.12.005 · Cited by 2
“When levels of intracellular tau protein increase, they may be secreted into the extracellular space (Sim ´ on et al., 2012a) and exert toxic effects on cells (Andorfer et al., 2005; G ´ omez-Ramos et al., 2008).”
Bukhari, H., Nithianandam, V., Battaglia, R. A., Cicalo, A., Sarkar, S., Comjean, A., Hu, Y., Leventhal, M. J., Dong, X., & Feany, M. Β. (2024) · Genome Research · doi:10.1101/gr.278576.123 · Cited by 11
“In Figure 2”
InfluentialBoutajangout, A., Zhang, W., Kim, J., Abdali, W., Prelli, F., & Wısnıewskı, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.640677 · Cited by 4
“The 8c mice express a tau transgene, derived from a human PAC driven by the tau promoter, and produce all human tau isoforms (Andorfer et al., 2005).”
BackgroundCurrent and future treatments of memory complaints and Alzheimer’s disease
Summers, W. K. (2011) · Therapy · doi:10.2217/thy.11.60 · Cited by 2
Tau Oligomers as Potential Drug Target for Alzheimer Disease (AD) Treatment
Kayed, R. (2011) · InTech eBooks · doi:10.5772/16682 · Cited by 1
“Cell death and synaptic lesions occurred independently of NFT formation (h-tau mice) expressing non-mutant human tau (Andorfer et al. 2005, Polydoro et al. 2009); hippocampal synapse loss, impaired synaptic function and microgliosis precede the formation of NFT in the P301S mutant human tau…”
BackgroundRole of Oxidative Insult and Neuronal Survival in Alzheimer’s and Parkinson’s Diseases
Nunomura, A., Moreira, P. I., Zhu, X., Cash, A., Smith, M. A., & Perry, G. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_14 · Cited by 2
Melchior, B., Browning, M., McCartan, R., Lai, C., Hahn-Townsend, C., Gratkowski, A., Morin, A., MULLAN, M. J., Crawford, F., Grifman, M., et al. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00843 · Cited by 1
“Transgenic mice expressing Human Tau on a C57BL/6 and null murine tau background (hTau generated as previously described [25, 26]) were purchased from Jackson Laboratories (Stock # 005491), Bar Harbor, Maine.”
Tau condensation on DNA and localization on centromeres: A potential link to cell divisionPreprint
Park, C., Jung, J., Hong, Y., Lee-Eom, C., Rah, S., Yang, K., Shin, J., Jeong, A., Hong, S., Lee, J.-B., et al. (2024) · bioRxiv · doi:10.1101/2024.09.24.614852 · Cited by 1
“Given the link between aberrant cell cycle activation in postmitotic neurons and neurodegeneration ( 76 – 78 ), as well as the reduction of adult hippocampal neurogenesis in cognitive decline ( 79 , 80 ), it is plausible that defective tau function during cell division could have broader…”
BackgroundSinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000104 · Cited by 15
Broad kinase inhibition mitigates early neuronal dysfunction and cognitive deficits in tauopathyPreprint
Koren, S. A., Hamm, M. J., Cloyd, R., Fontaine, S. N., Chishti, E. A., Lanzillotta, C., Rodriguez-Rivera, J., Ingram, A., Bell, M. C., Escobar, S. M. G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.31.229583 · Cited by 1
From Protein Tangles to Genetic Variants: The Central Role of Tau in Neurodegenerative Disease
Julia, H., & Wade‐Martins, R. (2011) · InTech eBooks · doi:10.5772/29839 · Cited by 1
“The animals displayed hyperphosphorylated tau and NFT formation as well as changes in neuronal morphology and a decrease in cortical thickness due to extensive cell death (Andorfer et al., 2005; Andorfer et al., 2003).”
Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
Laumet, G. O. (2010) · theses.fr (ABES) · doi:10.70675/94126786zf990z488ezb471z5f1d5686766c
“Ces résultats ont été appuyés par les travaux d’Andorfer et ses collaborateurs qui ont observés dans un modèle murin sur-exprimant la protéine Tau humaine mutée (P310L, mutation responsable de certain type de démence fronto-temporale), une mort neuronale indépendante des DNF (Andorfer et al., 2005).”
BackgroundCurrent and Future Therapies for Alzheimer Disease
Chakrabarty, P., Das, P., & Golde, T. E. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch34 · Cited by 1
Alzheimer Disease: Protein Misfolding, Model Systems, and Experimental Therapeutics
Price, D. L., Savonenko, A. V., Li, T., Lee, M. K., & Wong, P. C. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch12 · Cited by 1
Molecular Defects in the DM Central Nervous System
Kimura, T. (2018) · Springer eBooks · doi:10.1007/978-981-13-0508-5_7
Stephens, G. S., You, J. C., Fu, C.-H., & Chin, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21126-7 · Cited by 1
Vasconcelos, B., Bird, M., Stancu, I., Terwel, D., & Dewachter, I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00006-3 · Cited by 2
Active and Passive Immunotherapy Against Tau: Effects and Potential Mechanisms
Yanamandra, K., Diamond, M. I., & Holtzman, D. M. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3560-4_9
Ren, Y., Sahara, N., Giasson, B. I., & Lewis, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00055-x · Cited by 4
Apoptosis in Neurodegenerative Diseases
Liang, Q., & Zhang, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-381-7_21 · Cited by 1
Cdk5 as a Drug Target for Alzheimer’s Disease
Lau, L., & Hicks, C. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-78887-6_18 · Cited by 2
SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain
Huang, H., Shi, C. H., Yang, W., Piña-Crespo, J. C., Bhatnagar, J., Curatolo, J., Murad, R., Shah, P., Campos, A., Houser, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed6825 · Cited by 1
Choi, D., & Choi, H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0503-5 · Cited by 72
Imaging of Neurotransmitter Systems in Dementia
Hasselbalch, S., & Knudsen, G. (2016) · CRC Press eBooks · doi:10.3109/9781420016819-12
MicroRNAs modulate cell death mechanisms in neurodegenerative disorders
Singh, A., Subramanian, M., & Singh, A. (2026) · Aging advances. · doi:10.4103/agingadv.agingadv-d-26-00023
Hill, E., Linehan, J. M., Farmer, M., Jakubcova, T., Hamdan, S., Tomlinson, A., Purro, S. A., Argentina, F., Jones, E. L., Kaye, N., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03009-2
“Furthermore, the observed dissociation between tau burden and toxicity aligns with previous studies showing functional preservation despite persistent pathology [2, 3, 10, 38, 42, 44, 46].”
Pyruvate kinase M2 in Alzheimer’s disease: from dysregulation to therapeutic inhibition
Gojani, E. G., Sutherland, R. J., & Mohajerani, M. H. (2026) · Brain Communications · doi:10.1093/braincomms/fcag054 · Cited by 1
“It drives abnormal neuronal cell-cycle re-entry, 103–107 enhances A β plaque formation 32,108 and promotes Tau hyperphosphorylation 109,110 through both transcriptional regulation and PTMs.”
Hill, E., Patel, M., Ribes, J. M., Linehan, J. M., Zhang, F., Farmer, M., Jakubcova, T., Hamdan, S., Tomlinson, A., Ercolani, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.19.635172
Investigating the effects of tau mutations in induced pluripotent stem cell-derived neurons
Ostick, J. L. (2019) · doi:10.17863/cam.42277
“In some mouse models, such as in one expressing human tau but not mouse tau, cell death and dysfunction precede the detection of sarkosyl-insoluble tau filaments and thioflavin-S positive tau inclusions, implicating soluble tau species (Andorfer et al., 2005).”
BackgroundNovel Genetic Models to Study the Role of Inflammation in Brain Injury-Induced Alzheimer's Pathology
Lamb, B., & Kokiko-Cochran, O. (2014) · doi:10.21236/ada612110
“Davies and colleagues developed a genomic mouse model of human MAPT pathology (termed hTau) by expressing the entire wild-type human MAPT gene in mice lacking the endogenous Mapt gene [9, 10].”
BackgroundSrc Family Kinases in Intracerebral Hemorrhage
Liu, D. (2014) · InTech eBooks · doi:10.5772/58488 · Cited by 1
“Increasing evidence have revealed that aberrant cell cycle re-entry leads to neuronal death [8,32,37-64], and cell cycle inhibition via blocking SFKs can protect neurons from death post-ICH [8].”
BackgroundLaurent, C. (2013) · theses.fr (ABES) · doi:10.70675/03ed9498z69bfz4543zb662z2c85c03cea04
“…2009), or il semble aujourd’hui que ces espèces constituent plutôt un réservoir de protéines tau à la toxicité modérée (Morsch et al., 1999 ; Andorfer et al., 2005 ; Spires et al., 2006), et que les espèces oligomériques de tau, plus solubles, soient à l’origine des effets toxiques de tau…”
“As seen in mice bearing the non-mutant human tau gene, dying neurons did not contain NFT, while those bearing NFT maintained robust nuclear morphology (Andorfer et al. 2005).”
BackgroundKorenova, M., & Stožická, Z. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9378-2
“Over the last 10 years, the researchers interested in the field of neurodegenerative tauopathies made important findings, mostly thanks to development of transgenic animals expressing wild type, mutated or tau protein corresponding to the pathological truncation seen in AD (Probst et al. 2000; Gotz et al. 2001; Tanemu…”
BackgroundFunctional Applications of Stable Tau Oligomers in Cell Biology and Electrophysiology Studies
Hill, E., Moffat, K. G., Wall, M. J., Zetterberg, H., Blennow, K., & Karikari, T. K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2597-2_11
Alquézar, C., & Martín‐Requero, Á. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00012-8
Animal Models of Neurodegenerative Diseases
Baglietto‐Vargas, D., Ager, R. R., Medeiros, R., & LaFerla, F. M. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780190233563.003.0014
“Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.”
Perspective, Summary, and Directions for Future Research on Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00010-0
Neurodegenerative Diseases and Dementia
Janus, C., & Welzl, H. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_6 · Cited by 2
Assembly and Disassembly of Protein Aggregates
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800186-8.00006-7
Differential Roles for the Retinoblastoma Protein in Cycling and Quiescent Neural Populations
Andrusiak, M. G. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-2941
Modulation of growth factor-induced ERK signaling by the microtubule associated protein tau
Leugers, C. J. (2010) · doi:10.17077/etd.44cmdeo5
“Similarly, a cell culture model expressing P301L mutant tau was found to up-regulate numerous genes associated with cell cycle re-entry upon exposure to Aβ including cdk1, cdk4, and PCNA (Hoerndli et al., 2007).”
BackgroundInfluentialBiological Models in Frontotemporal Dementias
Brion, J. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01241-9
“In addition, expression of wild-type tau could induce cell death independently of NFT formation, possibly mediated by cell-cycle re-entry (Andorfer et al. 2005).”
BackgroundChapter 4 Tau Protein and the Dementias
Goedert, M., & Spillantini, M. G. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70055-3
Duff, K., Krishnamurthy, P., Planel, E., & Hutton, M. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_13
Self-citation
Metadata
- Authors
- Andorfer, C., Acker, C. M., Kress, Y., Hof, P. R., Duff, K., & Davies, P.
- Affiliations
- Albert Einstein College of Medicine (US)
- Icahn School of Medicine at Mount Sinai (US)
- Nathan Kline Institute for Psychiatric Research (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-06-01
- Volume
- 25
- Issue
- 22
- Pages
- 5446-5454
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6725006
- OpenAlex
- W2016758992
- Cited by
- 511
- References
- 74
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 10 · 2023: 28 · 2022: 18 · 2021: 16 · 2020: 26 · 2019: 17 · 2018: 20 · 2017: 20 · 2016: 17 · 2015: 22 · 2014: 29 · 2013: 25 · 2012: 26
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (38623)
- National Institute on Aging (R37AG022102, AG022102, R01AG022102)
- National Institute of Mental Health (38623)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- tau protein, cell cycle re-entry, neuronal cell death, neurofibrillary tangles, tauopathy, Alzheimer's disease, transgenic mice, neurodegeneration, DNA synthesis, tau filaments
- MeSH terms
- Aging, Animals, Brain, Bromodeoxyuridine, Cell Cycle, Humans, Mice, Transgenic, Nerve Degeneration, Nerve Tissue Proteins, Neurons, Neurofibrillary Tangles, tau Proteins, Cell Death, Protein Isoforms, Mice, DNA Fragmentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review